A reverse transcriptase-PCR based assay for in-vitro antibiotic susceptibility testing of Chlamydia pneumoniae

Journal of Antimicrobial Chemotherapy

Volumn 37, Issue 4, 1996, Pages 677-685

  Khan, M A ^a,c   Potter, C W ^b   Sharrard, R M ^b  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

^c ST HELIER HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CIPROFLOXACIN; DOXYCYCLINE; ERYTHROMYCIN; SULFAMETHOXAZOLE; TETRACYCLINE; TRIMETHOPRIM;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GROWTH; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; GROWTH INHIBITION; IMMUNOFLUORESCENCE TEST; INTERMETHOD COMPARISON; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; REPRODUCIBILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTI-BACTERIAL AGENTS; BASE SEQUENCE; CHLAMYDOPHILA PNEUMONIAE; DOXYCYCLINE; ERYTHROMYCIN; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; OLIGONUCLEOTIDE PROBES; POLYMERASE CHAIN REACTION; TETRACYCLINE; TRANSCRIPTION, GENETIC;

EID: 0029958829     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/37.4.677     Document Type: Article

References (16)

1. Chirgwin, K., Roblin, P. M. & Hammerschlag, M. R. (1989). In-vitro susceptibilities of Chlamydia pneumoniae (Chlamydia sp. strain TWAR). Antimicrobial Agents and Chemotherapy 33, 1634-5.
2. Cooper, M. A., Baldwin, D., Mathews, R. S., Andrews, J. M. & Wise, R. (1991). In-vitro susceptibility of Chlamydia pneumoniae (TWAR) to seven antimicrobial agents. Journal of Antimicrobial Chemotherapy 28, 407-13.
3. Fenelon, L. E., Mumtaz, G. & Ridgway, G. L. (1990). The in-vitro antibiotic susceptibility of Chlamydia pneumoniae. Journal of Antimicrobial Chemotherapy 26, 763-7.
4. Grayston, J. T., Aldos, M. B., Easton, A., Wang, S.-P., Kuo, C.-C., Campbell, L. A. et al. (1993). Evidence that Chlamydia pneumoniae causes pneumonia and bronchitis. Journal of Infectious Diseases 168, 1231-5.
5. Grayston, J. T., Campbell, L. A., Kuo, C.-C., Mordhorst, C. H., Saikku, P., Thom, D. H. et al. (1990). A new respiratory pathogen: Chlamydia pneumoniae strain TWAR. Journal of Infectious Diseases 161, 618-25.
6. Grayston, J. T., Kuo, C.-C., Campbell, L. A. & Wang, S.-P. (1989). Chlamydia pneumoniae sp. nov. for Chlamydia sp. strain TWAR. International Journal of Systemic Bacteriology 39, 88-90.
7. Kornak, J. M., Kuo, C.-C. & Campbell, L. A. (1991). Sequence analysis of the gene encoding the Chlamydia pneumoniae DnaK protein homolog. Infection and Immunity 59, 721-5.
8. Kuo, C.-C. & Grayston, J. T. (1988). In-vitro drug susceptibility of Chlamydia sp. strain TWAR. Antimicrobial Agents and Chemotherapy 32, 257-8.
9. Kuo, C.-C., Shor, A., Campbell, L. A., Fukushi, H., Patton, D. L. & Grayston, J. T. (1993). Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. Journal of Infectious Diseases 167, 841-9.
10. Patel, B. K. R., Banerjee, D. K. & Butcher, P. D. (1993). Determination of Mycobacterium leprae viability by polymerase chain reaction amplification of 71-kDa heat-shock protein mRNA. Journal of Infectious Diseases 168, 799-800.
11. Ridgway, G. L. (1992). The chemotherapy of Chlamydia infections. In Second Proceedings of the European Society for Chlamydia Research, Bologna, Italy (Mardh, P.-A., LaPlaca, M. & Ward, M., Ed.), pp. 249-53.
12. Roblin, P. M. & Hammerschlag, M. R. (1990). In-vitro activity of sparafloxacin (C1-978, AT 4140) and two other quinolones against Chlamydia trachomatis and Chlamydia pneumoniae. In Program and Abstracts of the Thirtieth Interscience Conference on Antimicrobial Agents and Chemotherapy, Atlanta, GA, 1990. Abstract 22, p. 90. American Society for Microbiology, Washington, DC.
13. Roblin, P. M., Montalban, G. & Hammerschlag, M. R. (1994). Susceptibilities to clarithromycin and erythromycin of isolates of Chlamydia pneumoniae from children with pneumonia. Antimicrobial Agents and Chemotherapy 38, 1588-9.
14. Saikku, P., Mattila, K., Nieminen, M. S., Leinonen, M., Ekman, M. R., Makela, P. H. et al. (1988). Serological evidence of an association of novel Chlamydia, TWAR, with chronic heart disease and acute myocardial infarction. Lancet ii, 983-6.
15. Stephens, R. S. (1988). Chlamydial genetics. In Microbiology of Chlamydia. (Barron, A. L., Ed.) pp. 111-34. CRC Press, Boca Raton, FL.
16. Yuan, Y., Zhang, Y.-X., Watkins, N. G. & Caldwell, H. D. (1989). Nucleotide and deduced amino acid sequences for the four variable domains of the major outer membrane proteins of 15 Chlamydia trachomatis serovars. Infection and Immunity 57, 1040-9.